{"id":"NCT00413894","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.","officialTitle":"An Open Label Study of the Effect of Intravenous Mircera on Hemoglobin Levels in Anemic Patients With Chronic Kidney Disease Who Are on Dialysis, and Who Have Previously Received Epoetin Alfa or Beta or Darbepoetin Alfa Treatment.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2006-12-20","resultsPosted":"2016-02-15","lastUpdate":"2016-02-15"},"enrollment":424,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"methoxy polyethylene glycol-epoetin beta [Mircera]","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"This single arm study will assess the efficacy and safety of intravenous Mircera, administered with pre-filled syringes, for the treatment of anemia in patients with chronic kidney disease who are on dialysis, and who have previously received treatment with epoetin alfa or beta or darbepoetin alfa. Patients will receive monthly intravenous injections of Mircera, with the starting dose derived from the dose of epoetin alfa or beta or darbepoetin they were receiving in the week preceding study start. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.","primaryOutcome":{"measure":"Percentage of Participants With Hb Levels Within 11.0-12.5 Grams Per Deciliter (g/dL) During Evaluation Phase","timeFrame":"Visits 8 to 10 (Months 6 to 8)","effectByArm":[{"arm":"C.E.R.A","deltaMin":31.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":105,"countries":["Germany"]},"refs":{"pmids":["26965694","20225992"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":174,"n":424},"commonTop":["Nasopharyngitis","Diarrhoea","Nausea","Bronchitis","Vomiting"]}}